Open AccessThis article is
- freely available
Synthesis and Biological Activities of a 3'-Azido Analogue of Doxorubicin Against Drug-Resistant Cancer Cells
School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China
Department of Chemistry and Biochemistry, The Ohio State University, Ohio 43210, USA
Jinan Central Hospital Affiliated to Shandong University, Jinan 250011, China
College of Chemistry and Environmental Sciences, Henan Normal University, Xinxiang 453002, China
College of Pharmacy, The University of Michigan, Michigan 48109, USA
College of Pharmacy, Nan Kai University, Tianjin 300071, China
* Authors to whom correspondence should be addressed.
Received: 13 February 2012; in revised form: 7 March 2012 / Accepted: 13 March 2012 / Published: 19 March 2012
Abstract: Doxorubicin (DOX), an anthracycline antibiotic, is one of the most active anticancer chemotherapeutic agents. The clinical use of DOX, however, is limited by the dose-dependant P-glycoprotein (P-gp)-mediated resistance. Herein, a 3′-azido analogue of DOX (ADOX) was prepared from daunorubicin (DNR). ADOX exhibited potent antitumor activities in drug-sensitive (MCF-7 and K562) and drug-resistant cell lines (MCF-7/DNR, K562/DOX), respectively. The drug resistance index (DRI) values of ADOX were much lower than that of DOX. The cytotoxicity experiments of ADOX or DOX against K562/DOX, with or without P-gp inhibitor, indicated that ADOX circumvents resistance by abolishing the P-gp recognition. This conclusion was further supported by drug influx/efflux flow cytometry experiments, as well as by molecular docking of ADOX to P-gp. In vivo animal tests, ADOX exhibited higher activity and less toxicity than DOX. The current data warranted ADOX for additional pre-clinical evaluations for new drug development.
Keywords: anthracycline; Azido; multidrug resistance; ADOX; P-gp
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Yu, S.; Zhang, G.; Zhang, W.; Luo, H.; Qiu, L.; Liu, Q.; Sun, D.; Wang, P.-G.; Wang, F. Synthesis and Biological Activities of a 3'-Azido Analogue of Doxorubicin Against Drug-Resistant Cancer Cells. Int. J. Mol. Sci. 2012, 13, 3671-3684.
Yu S, Zhang G, Zhang W, Luo H, Qiu L, Liu Q, Sun D, Wang P-G, Wang F. Synthesis and Biological Activities of a 3'-Azido Analogue of Doxorubicin Against Drug-Resistant Cancer Cells. International Journal of Molecular Sciences. 2012; 13(3):3671-3684.
Yu, Shuwen; Zhang, Guisheng; Zhang, Wenpeng; Luo, Huanhua; Qiu, Liyun; Liu, Qingfeng; Sun, Duxin; Wang, Peng-George; Wang, Fengshan. 2012. "Synthesis and Biological Activities of a 3'-Azido Analogue of Doxorubicin Against Drug-Resistant Cancer Cells." Int. J. Mol. Sci. 13, no. 3: 3671-3684.